Related references
Note: Only part of the references are listed.Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells
P. Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
Christoph Wyen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1l2 and their association with CYP3A4 expression
Jatinder Lamba et al.
DRUG METABOLISM AND DISPOSITION (2008)
The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research
Sydney Rosen et al.
AIDS (2007)
Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients
Jennifer Ford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection
Sara Colombo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacogenetics of HIV therapy
Andrew Owen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Genetic contribution to variable human CYP3A-mediated metabolism
JK Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
J Zhang et al.
PHARMACOGENETICS (2001)
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
A Geick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
